Edwards Lifesciences Corp. (EW)$85.78
Market Cap: 44.00 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Edwards Lifesciences Corp. (EW).
HEALTHCARE
MEDICAL DEVICES
DCF ready
Valuation
30.8x
EV/FCF, 3.3% FCF yield
Quality
10.4%
ROIC, 22.0% FCF margin
Growth
6.7%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 3.7x current ratio
Superinvestors
3
Top: David Rolfe (2.8%)
Strengths to research
- Free cash flow compounded at 15.6% over five years.
- Free cash flow margin is healthy at 22.0%.
- Debt/equity looks manageable at 0.0x.
- 3 tracked superinvestors report a position.
Watchouts
- P/E is elevated at 46.9x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for EW.
Grade C
62
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| EW Target | Edwards Lifesciences Corp. | $44.0B | 46.9x | 30.8x | 10.4% | 6.7% | 22.0% | 78.0% | -2.1x | N/A |
| DXCM | DEXCOM, INC. | $31.5B | 34.5x | 28.4x | 30.5% | 19.3% | 23.1% | 60.1% | -0.8x | N/A |
| STE | STERIS plc | $22.0B | 34.9x | 30.6x | 7.2% | 12.5% | 14.3% | 44.0% | 1.3x | N/A |
| MDT | Medtronic plc | $107.0B | 21.8x | 20.2x | 9.7% | 3.0% | 15.5% | N/A | -0.3x | N/A |
| SYK | Stryker Corp. | $145.6B | 37.7x | 33.0x | 14.5% | 11.8% | 17.1% | 64.0% | -0.6x | N/A |
| BSX | Boston Scientific | $154.2B | 29.8x | 41.6x | 11.9% | 15.2% | 18.2% | 69.0% | -0.4x | N/A |
| ABT | Abbott Labs | $230.7B | 23.5x | 31.8x | 10.0% | 5.1% | 16.7% | N/A | 0.5x | N/A |
| BIO | Bio-Rad Laboratories Inc. | $6.5B | 10.3x | 19.2x | 8.8% | 0.3% | 14.5% | 51.9% | 3.2x | N/A |
| BRKR | Bruker Corp. | $6.2B | -304.6x | 178.8x | -0.2% | 11.6% | 1.3% | 45.9% | 5.4x | N/A |
Financial Charts
No financial data available for EW (annual).
3 superinvestors own EW
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 1,097,578 | $88M | 0.25% | 0.0% |
| David Rolfe Wedgewood Partners | 170,969 | $14M | 2.83% | 0.0% |
| Torray Funds Torray Funds | 2,994 | $240,000 | 0.04% | 0.0% |